DBV Technologies appoints Michel de Rosen to its board of directors
16 May 2018 -

DBV Technologies SA (EPA: DBV) has appointed Michel de Rosen to its board of directors, the clinical-stage biopharmaceutical company announced on Wednesday.

De Rosen will replace George Horner III. His appointment will be proposed at the upcoming Ordinary and Extraordinary General Meeting, taking place on 22 June in Montrouge, France.

De Rosen currently serves as chairman of the board of Faurecia (EPA: EO), a global supplier of automotive equipment, and chairman of the board of pharmaceutical company Pharnext (EPA: ALPHA).

His previous roles have included serving as chairman and CEO of Eutelsat, chairman and CEO of ViroPharma, and chairman and CEO of Rhône-Poulenc Santé. He has also held key positions at the French Ministries of Finance, Defence, Industry and Telecommunications.

With the addition of de Rosen, DBV's board now comprises eight directors.